Inventor
HUANG DEHUA
US68 patents
⚠️ This page may combine multiple inventors who share the name “HUANG DEHUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
12 patentsUS9512124B2Dec 6, 2016
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC32 citations96
US7981893B2Jul 19, 2011
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC90 citations94
US9737541B2Aug 22, 2017
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC12 citations91
US8372976B2Feb 12, 2013
Methods of treatment comprising the administration of heteroaryl compounds
SIGNAL PHARM LLC40 citations91
US9556126B2Jan 31, 2017
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC10 citations82
US9156798B2Oct 13, 2015
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC5 citations82
US10940152B2Mar 9, 2021
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC1 citations72
US10646493B2May 12, 2020
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC1 citations72
US10398700B2Sep 3, 2019
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations72
US10149849B2Dec 11, 2018
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations72
US9783505B2Oct 10, 2017
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations71
US11590139B2Feb 28, 2023
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC0 citations61
ALLERGAN SALES INC
10 patentsUS6313107B1Nov 6, 2001
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC44 citations96
US6387892B1May 14, 2002
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC18 citations93
US6291677B1Sep 18, 2001
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC51 citations93
US6252090B1Jun 26, 2001
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC28 citations93
US6093838AJul 25, 2000
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
ALLERGAN SALES INC39 citations93
US6531599B2Mar 11, 2003
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC4 citations74
US6399774B1Jun 4, 2002
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC6 citations74
US6387951B1May 14, 2002
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC8 citations74
US6369225B1Apr 9, 2002
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC13 citations74
US6359135B1Mar 19, 2002
Compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN SALES INC8 citations74
CELGENE CORP
6 patentsUS11634407B2Apr 25, 2023
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP5 citations73
US11739075B2Aug 29, 2023
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP3 citations71
US11560371B2Jan 24, 2023
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP3 citations71
US12227490B2Feb 18, 2025
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US12103920B2Oct 1, 2024
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US11945804B2Apr 2, 2024
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
ALLERGAN INC
3 patentsUS6495552B2Dec 17, 2002
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
ALLERGAN INC16 citations93
US6720423B2Apr 13, 2004
Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
ALLERGAN INC41 citations91
US6855512B2Feb 15, 2005
Methods for identifying inhibitors of cytochrome P450RAI
ALLERGAN INC6 citations74
US NAVY
3 patentsHUANG DEHUA
3 patentsCISCO TECH INC
2 patentsSIGNAL PHARMACEUTICAL LLC
2 patentsUS9428509B2Aug 30, 2016
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARMACEUTICAL LLC6 citations81
US9346812B2May 24, 2016
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARMACEUTICAL LLC6 citations81
US HEALTH
2 patentsHOWARTH THOMAS R
2 patentsMERCK & CO INC
2 patentsCOSFORD NICHOLAS D
1 patentMERCK SHARP & DOHME
1 patentLONG YAN DE YU LIGHTING CO LTD
1 patentShowing the top 50 of 68 patents by PatentIndex Score.